Literature DB >> 11404609

Cause of death in patients with well-differentiated thyroid carcinoma.

N J Beasley1, P G Walfish, I Witterick, J L Freeman.   

Abstract

OBJECTIVES: The aim of this study is to examine in detail patients dying of well-differentiated thyroid carcinoma. STUDY
DESIGN: A retrospective chart review with follow-up.
METHODS: Data were collected from 522 consecutive cases of differentiated thyroid carcinoma treated by one endocrinologist and four surgeons at Mount Sinai Hospital, Toronto, Ontario, Canada, from 1964 to 1999.
RESULTS: Ten patients died as a direct result of thyroid carcinoma; 19 other deaths were unrelated. Five of 102 patients were men (5%) and 5 of 420 were women (1%); the median age at diagnosis was 68.5 years (range, 49-82 y). No cases were stage I; three, stage II; two, stage III; and five, stage IV. Pathologically papillary carcinoma was found in six of the patients who died, follicular carcinoma in three patients, and Hurtle cell carcinoma in one patient. The causes of death were local invasion or compression of the trachea in two cases and distant metastases in eight patients. Median survival was 3.5 years (range, 1 mo-20 y).
CONCLUSIONS: All patients dying of well-differentiated thyroid carcinoma had neck nodes, extrathyroidal spread, or distant metastases at presentation and were older than 49 years of age. Many presented because of their distant metastases. Death resulting from local disease was unusual, with most patients dying of distant metastases.

Entities:  

Mesh:

Year:  2001        PMID: 11404609     DOI: 10.1097/00005537-200106000-00011

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  5 in total

1.  Preoperative determination of serum thyroglobulin to identify patients with differentiated thyroid cancer who may present recurrence without increased thyroglobulin.

Authors:  B Gibelli; P Tredici; C De Cicco; L Bodei; M T Sandri; G Renne; R Bruschini; N Tradati
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-04       Impact factor: 2.124

2.  Long-term eradication of locally recurrent invasive follicular thyroid carcinoma after taxane-based concomitant chemoradiotherapy.

Authors:  Marshall Tulloch-Reid; Monica C Skarulis; Steven I Sherman; Nicholas J Sarlis; Libero Santarpia
Journal:  Anticancer Res       Date:  2009-11       Impact factor: 2.480

3.  Differentiated thyroid cancer in navarra (Spain): historic cohort results (1987-2003).

Authors:  María Pilar Salvador Egea; Ana Aranzazu Echegoyen Silanes; Eduardo Layana Echezuri; Emma Anda Apiñariz; Ana Puras Gil; Edelmiro Menéndez Torre; Lluis Forga Llenas; Amaya Sainz de Los Terreros
Journal:  ISRN Oncol       Date:  2011-07-31

4.  Tracheal and Cricotracheal Resection With End-to-End Anastomosis for Locally Advanced Thyroid Cancer: A Systematic Review of the Literature on 656 Patients.

Authors:  Cesare Piazza; Davide Lancini; Michele Tomasoni; Anil D'Cruz; Dana M Hartl; Luiz P Kowalski; Gregory W Randolph; Alessandra Rinaldo; Jatin P Shah; Ashok R Shaha; Ricard Simo; Vincent Vander Poorten; Mark Zafereo; Alfio Ferlito
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-11       Impact factor: 5.555

5.  Hürthle cell carcinoma: diagnostic and therapeutic implications.

Authors:  Mohamed R Hanief; Laszlo Igali; Dimitrie Grama
Journal:  World J Surg Oncol       Date:  2004-08-11       Impact factor: 2.754

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.